Pfizer seeks full FDA approval of Paxlovid as questions about its benefits grow
Bio Pharma Dive
JUNE 30, 2022
Converting Paxlovid’s emergency authorization to a standard clearance could further broaden its use. But the drug may not meaningfully help people who are vaccinated, and concerns about its potency against emerging variants are growing
Let's personalize your content